Shopping Cart
Remove All
Your shopping cart is currently empty
Litifilimab (BIIB059) is a humanizedantibody targeting the plasma cell-like dendritic cell specific antigen (BDCA2) and C-type lectin structural domain family 4, member C (CLEC4C) for the study of cutaneous lupus erythematosus.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $217 | - | In Stock | |
| 5 mg | $456 | - | In Stock | |
| 10 mg | $728 | - | In Stock | |
| 25 mg | $1,080 | - | In Stock | |
| 50 mg | $1,480 | - | In Stock |
| Description | Litifilimab (BIIB059) is a humanizedantibody targeting the plasma cell-like dendritic cell specific antigen (BDCA2) and C-type lectin structural domain family 4, member C (CLEC4C) for the study of cutaneous lupus erythematosus. |
| Synonyms | BIIB059, BIIB 059 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2407378-48-5 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.